Shandong Realcan Pharmaceutical Co Ltd (002589) — Capital Reinvestment Ratio
Shandong Realcan Pharmaceutical Co Ltd (002589) has a Capital Reinvestment Ratio of 2.12x as of June 2025, meaning it reinvests 2% of its operating cash flow (CN¥24.86 Million) in capital expenditures (CN¥52.73 Million). See how much free cash does Shandong Realcan Pharmaceutical Co Ltd generate to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Shandong Realcan Pharmaceutical Co Ltd Capital Reinvestment Ratio (2009–2025)
This chart tracks Shandong Realcan Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 9 annual periods.
Annual Capital Reinvestment Ratio for Shandong Realcan Pharmaceutical Co Ltd (2009–2025)
Year-by-year Capital Reinvestment Ratio for Shandong Realcan Pharmaceutical Co Ltd from 2009 to 2025. For live market cap and broader valuation context, see Shandong Realcan Pharmaceutical Co Ltd (002589) market capitalisation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 1.95x | CN¥13.76 Million | CN¥26.82 Million | ▲ +180.4% |
| 2024 | 0.70x | CN¥160.44 Million | CN¥111.53 Million | ▼ -80.8% |
| 2023 | 3.62x | CN¥82.47 Million | CN¥298.38 Million | ▲ +1007.0% |
| 2022 | 0.33x | CN¥523.07 Million | CN¥170.96 Million | ▼ -68.6% |
| 2021 | 1.04x | CN¥442.95 Million | CN¥461.09 Million | ▼ -14.5% |
| 2020 | 1.22x | CN¥414.96 Million | CN¥505.39 Million | ▲ +172.9% |
| 2019 | 0.45x | CN¥2.09 Billion | CN¥934.87 Million | ▼ -16.5% |
| 2010 | 0.53x | CN¥70.56 Million | CN¥37.72 Million | ▲ +70.6% |
| 2009 | 0.31x | CN¥61.38 Million | CN¥19.23 Million | — |